MIND MEDICINE ($MNMD) posted quarterly earnings results on Thursday, July 31st. The company reported earnings of -$0.50 per share, missing estimates of -$0.37 by $0.13. The company also reported revenue of $0, equaling estimates of $0 by $0.
You can see Quiver Quantitative's $MNMD stock page to track data on insider trading, hedge fund activity, congressional trading, and more.
MIND MEDICINE Insider Trading Activity
MIND MEDICINE insiders have traded $MNMD stock on the open market 7 times in the past 6 months. Of those trades, 0 have been purchases and 7 have been sales.
Here’s a breakdown of recent trading of $MNMD stock by insiders over the last 6 months:
- ROBERT BARROW (Chief Executive Officer) has made 0 purchases and 2 sales selling 47,699 shares for an estimated $323,080.
- MARK SULLIVAN (Chief Legal Officer) has made 0 purchases and 2 sales selling 18,067 shares for an estimated $122,461.
- DANIEL KARLIN (Chief Medical Officer) has made 0 purchases and 2 sales selling 14,684 shares for an estimated $99,441.
- CARRIE LIAO (Chief Accounting Officer) sold 2,347 shares for an estimated $15,818
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
MIND MEDICINE Hedge Fund Activity
We have seen 77 institutional investors add shares of MIND MEDICINE stock to their portfolio, and 76 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- OCTAGON CAPITAL ADVISORS LP added 15,332,000 shares (+508.0%) to their portfolio in Q1 2025, for an estimated $89,692,200
- TRI LOCUM PARTNERS LP removed 820,793 shares (-100.0%) from their portfolio in Q1 2025, for an estimated $4,801,639
- ROSALIND ADVISORS, INC. added 420,000 shares (+inf%) to their portfolio in Q1 2025, for an estimated $2,457,000
- BLACKROCK, INC. removed 354,340 shares (-5.8%) from their portfolio in Q1 2025, for an estimated $2,072,888
- DEEP TRACK CAPITAL, LP removed 316,594 shares (-11.2%) from their portfolio in Q1 2025, for an estimated $1,852,074
- CITADEL ADVISORS LLC added 291,630 shares (+239.5%) to their portfolio in Q1 2025, for an estimated $1,706,035
- COMMODORE CAPITAL LP added 216,575 shares (+5.0%) to their portfolio in Q1 2025, for an estimated $1,266,963
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
MIND MEDICINE Analyst Ratings
Wall Street analysts have issued reports on $MNMD in the last several months. We have seen 3 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- Chardan Capital issued a "Buy" rating on 05/09/2025
- Baird issued a "Outperform" rating on 03/07/2025
- HC Wainwright & Co. issued a "Buy" rating on 03/07/2025
To track analyst ratings and price targets for MIND MEDICINE, check out Quiver Quantitative's $MNMD forecast page.
MIND MEDICINE Price Targets
Multiple analysts have issued price targets for $MNMD recently. We have seen 3 analysts offer price targets for $MNMD in the last 6 months, with a median target of $20.0.
Here are some recent targets:
- Rudy Li from Chardan Capital set a target price of $20.0 on 05/09/2025
- Joel Beatty from Baird set a target price of $16.0 on 03/07/2025
- Patrick Trucchio from HC Wainwright & Co. set a target price of $55.0 on 03/07/2025
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
